Interstitial lung disease (ILD) occurs when there is scarring within the lungs and is the most common form of lung involvement in systemic sclerosis. In ILD, ...

15 февр. 2024 г. · Pulmonary fibrosis is a lung disease that occurs when lung tissue becomes damaged and scarred. This thickened, stiff tissue makes it harder for the lungs to ...

The key elements of scleroderma lung disease involve 1) inflammation (potentially treatable); 2) lung scarring (not reversible but potentially preventable); and ...

Fibrotic and vascular pulmonary manifestations of SSc, including interstitial lung disease (ILD) and pulmonary hypertension (PH), are the leading cause of ...

Systemic sclerosis is an autoimmune connective tissue disease, which is characterised by immune dysregulation and progressive fibrosis that typically affects ...

15 янв. 2024 г. · Scleroderma causes life-threatening lung problems in some people due to interstitial lung disease and/or pulmonary hypertension.

The disease is driven by epithelial injury, reflected by markers in the serum, such as surfactant proteins and KL-6. In addition, mediators that are produced by ...

27 февр. 2020 г. · Systemic sclerosis-associated interstitial lung disease is the end result of the interplay between fibrosis, autoimmunity, inflammation, and ...

Systemic sclerosis (systemic scleroderma) is a chronic disease associated with skin thickening and changes to blood vessels, particularly those supplying ...

There are five main categories of pulmonary fibrosis that have identifiable causes. They are: Drug-induced, Radiation-induced, Environmental, Autoimmune, and ...